(The PDF file is accessible to physically and visually impaired persons)
For each pharma applications, the guide allows you to choose different products by functionality, and by conformity to the main pharmacopeias.
CRYSMEB is a unique low methylated derivative of betacyclodextrin. The degree of methylation is controlled in such a manner that the derivative has an advantageous profile of solubilising power and biological tolerance.
CRYSMEB could be an alternative solution for cyclodextrin-drug formulations.
A technical brochure incorporating a general introduction to this type of excipient, with detailed information on the physical, chemical and microbiological characteristics of LYCASIN® 80/55. Its biological properties and examples of pharmaceutical applications are also included.